Targeting oncogene-induced cellular plasticity for tumor therapy

Abstract

Cellular plasticity, the remarkable adaptability of cancer cells to survive under various stress conditions, is a fundamental hallmark that significantly contributes to treatment resistance, tumor metastasis, and disease recurrence. Oncogenes, the driver genes that promote uncontrolled cell proliferation, have long been recognized as key drivers of cellular transformation and tumorigenesis. Paradoxically, accumulating evidence demonstrates that targeting certain oncogenes to inhibit tumor cell proliferation can unexpectedly induce processes like epithelial-to-mesenchymal transition (EMT), conferring enhanced invasive and metastatic capabilities. In this review, we summarize the latest models elucidating the biology of oncogenes that concurrently promote cell proliferation while inhibiting metastasis. We suggest that the complexity of oncogene-induced cellular plasticity, involving the participation of multiple signaling pathways and mechanisms, necessitates a multifaceted approach, prompting a shift towards precision targeting strategies that can effectively target oncogenes without exacerbating metastatic potential.

Keywords

Cellular plasticity / Oncogene / EMT / Metastasis / Precision medicine

References

[] Banerjee S, Grochot R, Shinde R, Lima J, Krebs M, Rahman R, Little M, Tunariu N, Curcean A, Badham H, et al.. 725MO Phase I study of the combination of the dual RAF/MEK inhibitor VS-6766 and the FAK inhibitor defactinib: Results of efficacy in low grade serous ovarian cancer. Ann Oncol, 2021, 32: S728,

[] Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer, 2021, 21: 162-180, pmcid: 8733955

[] Bossone SA, Asselin C, Patel AJ, Marcu KB. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci USA, 1992, 89: 7452-7456, pmcid: 49728

[] Brabletz T. To differentiate or not–routes towards metastasis. Nat Rev Cancer, 2012, 12: 425-436,

[] Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer, 2018, 18: 128-134,

[] Buscail L, Bournet B, Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol, 2020, 17: 153-168,

[] Canon J, Rex K, Saiki AY, Mohr C, Cooke K, Bagal D, Gaida K, Holt T, Knutson CG, Koppada N, et al.. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature, 2019, 575: 217-223,

[] Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther, 2023, 8: 70, pmcid: 9935926

[] Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med, 2008, 358: 1160-1174,

[] Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med, 2015, 372: 793-795, pmcid: 5101938

[] Dawson JC, Serrels A, Stupack DG, Schlaepfer DD, Frame MC. Targeting FAK in anticancer combination therapies. Nat Rev Cancer, 2021, 21: 313-324, pmcid: 8276817

[] Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, Rock JR, Harfe BD, Henson BJ, Kunzelmann K, et al.. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res, 2012, 72: 3270-3281, pmcid: 3694774

[] Felsher DW. Cancer revoked: oncogenes as therapeutic targets. Nat Rev Cancer, 2003, 3: 375-379,

[] Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell, 2013, 155: 750-764, pmcid: 4354734

[] Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer, 2014, 14: 430-439, pmcid: 4283800

[] Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol, 2003, 4: 657-665,

[] Gupta PB, Pastushenko I, Skibinski A, Blanpain C, Kuperwasser C. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance. Cell Stem Cell, 2019, 24: 65-78,

[] Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov, 2022, 12: 31-46,

[] Huang F, Shi Q, Li Y, Xu L, Xu C, Chen F, Wang H, Liao H, Chang Z, Liu F, et al.. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer. Cancer Res, 2018, 78: 6073-6085,

[] Huyghe A, Trajkova A, Lavial F. Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective. Trends Cell Biol, 2024, 34: 255-267,

[] Johmura Y, Sun J, Kitagawa K, Nakanishi K, Kuno T, Naiki-Ito A, Sawada Y, Miyamoto T, Okabe A, Aburatani H, et al.. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence. Nat Commun, 2016, 7: 10574, pmcid: 4754341

[] Li B, Zheng LS, Ye JY, Zhang CM, Zhou J, Huang QJ, Guo YH, Wang LQ, Yu P, Liu SR, et al.. CREB1 contributes colorectal cancer cell plasticity by regulating lncRNA CCAT1 and NF-κB pathways. Sci China Life Sci, 2022, 65: 1481-1497,

[] Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ, Bishop JM. MYC suppresses cancer metastasis by direct transcriptional silencing of alphav and beta3 integrin subunits. Nat Cell Biol, 2012, 14: 567-574, pmcid: 3366024

[] Paradis JS, Acosta M, Saddawi-Konefka R, Kishore A, Gomes F, Arang N, Tiago M, Coma S, Lubrano S, Wu X, et al.. Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma. Clin Cancer Res, 2021, 27: 3190-3200, pmcid: 8895627

[] Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL, Weinberg RA. Activation of PKA leads to mesenchymal-to-3epithelial transition and loss of tumor-initiating ability. Science., 2016, 351: 3680,

[] Pérez-González A, Bévant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat Cancer, 2023, 4: 1063-1082, pmcid: 7615147

[] Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo H-K, Jang HG, Jha AK, et al.. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature, 2011, 476: 346-350, pmcid: 3353325

[] Qian X, Hulit J, Suyama K, Eugenin EA, Belbin TJ, Loudig O, Smirnova T, Zhou ZN, Segall J, Locker J, et al.. p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis. Oncogene, 2013, 32: 2292-2303,

[] Rossi M, Altea-Manzano P, Demicco M, Doglioni G, Bornes L, Fukano M, Vandekeere A, Cuadros AM, Fernández-García J, Riera-Domingo C, et al.. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature, 2022, 605: 747-753, pmcid: 9888363

[] Schwitalla S. Tumor cell plasticity: the challenge to catch a moving target. J Gastroenterol, 2014, 49: 618-627,

[] Shiwarski DJ, Shao C, Bill A, Kim J, Xiao D, Bertrand CA, Seethala RS, Sano D, Myers JN, Ha P, et al.. To “Grow” or “Go”: TMEM16A Expression as a Switch between Tumor Growth and Metastasis in SCCHN. Clin Cancer Res, 2014, 20: 4673-4688, pmcid: 4160843

[] Sun R, Xie H-Y, Qian J-X, Huang Y-N, Yang F, Zhang F-L, Shao Z-M, Li D-Q. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression. Cancer Res, 2018, 78: 5274-5286,

[] Swanton C, Bernard E, Abbosh C, André F, Auwerx J, Balmain A, Bar-Sagi D, Bernards R, Bullman S, DeGregori J, et al.. Embracing cancer complexity: Hallmarks of systemic disease. Cell, 2024, 187: 1589-1616,

[] Vega S, Morales AV, Ocaña OH, Valdés F, Fabregat I, Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev, 2004, 18: 1131-1143, pmcid: 415638

[] Wang W, Li D, Xu Q, Cheng J, Yu Z, Li G, Qiao S, Pan J, Wang H, Shi J, et al.. G-quadruplexes promote the motility in MAZ phase-separated condensates to activate CCND1 expression and contribute to hepatocarcinogenesis. Nat Commun, 2024, 15: 1045, pmcid: 10844655

[] Yu Z-H, Lun S-M, He R, Tian H-P, Huang H-J, Wang Q-S, Li X-Q, Feng Y-M. Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression. Cancer Lett, 2017, 402: 142-152,

[] Zhang D, Zhang A, He X, Deng S. Variation in cancer risk between organs can not be explained by the degree of somatic clonal expansion. Adv Biotechnol, 2024, 2: 18,

[] Zhu Q, Krakowski AR, Dunham EE, Wang L, Bandyopadhyay A, Berdeaux R, Martin GS, Sun L, Luo K. Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol, 2007, 27: 324-339,

[] Zimmerman NP, Roy I, Hauser AD, Wilson JM, Williams CL, Dwinell MB. Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells. Mol Carcinog, 2015, 54: 203-215,

Funding

Key Technologies Research and Development Program of Anhui Province(2022YFA1303300); Innovative Research Group Project of the National Natural Science Foundation of China(32370588)